Bone Mineral Density Precision Study
Precision Assessment of Bone Mineral Density (BMD) Measurement With EOSedge™ - BMD Precision Study
1 other identifier
interventional
30
1 country
1
Brief Summary
The purpose of this research is to collect medical imaging data to allow for the comparison of bone mineral density measurements from two low-dose x-ray exams. The main question it aims to answer is: What is the precision measurement between the BMD assessments from 2 x-ray exams?
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 13, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2025
CompletedFirst Submitted
Initial submission to the registry
February 12, 2025
CompletedFirst Posted
Study publicly available on registry
February 17, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2025
CompletedFebruary 17, 2025
February 1, 2025
3 months
February 12, 2025
February 12, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
AP Spine BMD Precision
Calculation of EOSedge BMD from the 2 exams will be post-processed from the bi-planar EOSedge 2E radiographs, and is measured in g/cm² surface mass on four lumbar vertebrae (L1-L4) in the anteroposterior (AP) projection. Precision error will be calculated from the 2 exams.
1 day
Secondary Outcomes (2)
Hip BMD Precision
1 day
Lateral L2-L3 Precision
1 day
Study Arms (1)
Subjects indicated for EOSedge imaging
OTHERSubject receiving EOSedge imaging as SOC will also receive an additional EOSedge scan.
Interventions
Eligibility Criteria
You may qualify if:
- Subjects indicated for full-spine or whole-body radiography via EOSedge 2E biplanar imaging (e.g., in the preoperative evaluation of spine and/or other orthopaedic conditions)
- Male or female subjects who are at least 20 years of age at the time of imaging acquisition
- Written informed consent obtained from the potential subject or the subject's legal representative and ability for the subject to comply with the requirements of the study
You may not qualify if:
- Subjects who have been administered contrast agents or radionuclides within 7 days prior to scheduled radiographic imaging (EOS and DXA)
- Subjects who are pregnant or wanting to become pregnant during the timeframe of study participation (due to risks associated with radiographic imaging)
- Subjects with a BMI ≥ 35 kg/m2
- Subjects known to have severe degenerative changes or fracture deformity in the measurement area (i.e., lumbar spine L1-L4, bilateral femoral neck/trochanter; note that unilateral femoral evaluation is acceptable), as defined by the Investigator's determination of the likelihood of reasonably assessing bone mineral density of those areas
- Subjects known to have implants, hardware, devices, or other foreign material in the measurement area (i.e., lumbar spine L1-L4, bilateral femoral neck/trochanter; note that unilateral femoral evaluation is acceptable)
- Subjects unable to attain correct position and/or remain motionless for the measurement (e.g., subjects unable to stand unassisted in the EOS unit, or to lie appropriately in the DXA scanner)
- Subjects known to have extra or missing lumbar vertebrae (i.e., more or fewer than 5 mobile lumbar segments)
- Subjects participating in another clinical study which may compromise this study's results or compliance with this study's procedures
- Subjects with presence of a condition or abnormality that in the opinion of the Investigator would compromise the safety of the subject or the quality of the data
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
OrthoIndy
Fishers, Indiana, 46038, United States
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 12, 2025
First Posted
February 17, 2025
Study Start
November 13, 2024
Primary Completion
February 1, 2025
Study Completion
March 1, 2025
Last Updated
February 17, 2025
Record last verified: 2025-02